The point prevalence of an abnormal ankle-brachial index in antiphospholipid antibody negative patients with livedo reticularis: A controlled study [1]

Annals of the Rheumatic Diseases

Volumn 67, Issue 2, 2008, Pages 276-277

  Sangle, S ^a   Christodoulou, C ^a   Paul, S ^a   Hughes, G R V ^a   D'Cruz, D P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; TRIACYLGLYCEROL;

ADULT; ANKLE BRACHIAL INDEX; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FAMILY HISTORY; FEMALE; FETUS DEATH; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; LETTER; LIVEDO RETICULARIS; MORBIDITY; PATHOPHYSIOLOGY; PREGNANCY; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; SCREENING; SNEDDON SYNDROME; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE; STILLBIRTH; STROKE; TRIACYLGLYCEROL BLOOD LEVEL; VALVULAR HEART DISEASE; VASCULAR DISEASE; VEIN THROMBOSIS;

ADULT; FEMALE; HUMANS; LIVEDO RETICULARIS; MIDDLE AGED; PREVALENCE; RESEARCH DESIGN;

EID: 38749089101     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.074567     Document Type: Letter

References (10)

1. Uthman IW, Khamashta MA. Livedo Racemosa: A striking dermatological sign for the antiphospholipid syndrome. J Rheumatol 2006;33:2379-82.
2. Sangle S, D'Cruz DP, Hughes GRV. Livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies. Ann Rheum Dis 2005;64:147-8.
3. Sacks D, Bakal CW, Beatty PT, Becker GJ, Cardella JF, Raabe RD, et al. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease. A consensus statement developed by the standards division of the Society of Cardiovascular and International Radiology. J Vasc Interv Radiol 2002;13:353.
4. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
5. Kalashnikova LA, Nasanova EL, Borisenko W, Usman VB, Prudnikova LZ, Kovaljov VU. Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies. Clin Exp Rheumatol 1991;9:357-61.
6. Frances C, Papo T, Wechsler B, Laporte JL, Biousse V, Piette JC. Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients. Medicine (Baltimore) 1999;78:209-19.
7. Zelger B, Sepp N, Schmid KW, Hintner H, Klein G, Fritsch PO. Life history of cutaneous vascular lesions in Sneddon's syndrome. Hum Pathol 1992;23:668-75.
8. Sepp N, Zeiger B, Schuler G, Romani N, Fritsch P. Sneddon's syndrome - an inflammatory disorder of small arteries followed by smooth muscle proliferation. Immunohistochemical and ultrastructural evidence. Am J Surg Pathol 1995;19:448-53.
9. Roubey RAS. Antiphospholipid antibody-negative syndrome - other phospholipids. In: Khamashta MA, ed. Hughes syndrome. Antiphospholipid syndrome. London: Springer, 2000:253-60.
10. Hughes GRV, Khamashta MA. Seronegative antiphospholipid syndrome. Ann Rheum Dis 2003;62:1127.